![Omid Veiseh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omid Veiseh
Corporate Officer/Principal chez
Rice University
Profil
Omid Veiseh is the founder of Sigilon Therapeutics, Inc., founded in 2015.
Dr. Veiseh currently works as an Assistant Professor at William Marsh Rice University since 2017.
Dr. Veiseh holds a doctorate degree from the University of Washington.
Postes actifs de Omid Veiseh
| Sociétés | Poste | Début |
|---|---|---|
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Omid Veiseh
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Fondateur | 01/09/2017 |
Formation de Omid Veiseh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
